| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 03/25/2010 | WO2010033043A1 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 03/25/2010 | WO2010032219A1 Process for the preparation of tigecycline |
| 03/25/2010 | WO2009146539A8 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 03/25/2010 | WO2009141090A9 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them |
| 03/25/2010 | US20100076224 Novel trihalomethionine derivative and pharmaceutical product containing the same |
| 03/25/2010 | US20100075929 9-aminoacyl tetracycline compounds and methods of use thereof |
| 03/25/2010 | US20100075926 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 03/24/2010 | EP2166000A1 7-, 8- and 9-substituted tetracycline compounds |
| 03/24/2010 | CN101679218A Crystalline minocycline base and processes for its preparation |
| 03/24/2010 | CN101679213A New methods |
| 03/18/2010 | US20100069669 Preparation of Iodixanol |
| 03/18/2010 | US20100069453 Certain Chemical Entities, Compositions, and Methods |
| 03/18/2010 | US20100068139 Methods of radiofluorination of biologically active vectors |
| 03/17/2010 | EP2162427A1 Benzamides useful as s1p receptor modulators |
| 03/17/2010 | EP1713822B1 Hcv ns-3 serine protease inhibitors |
| 03/17/2010 | CN101675030A Process for purifying theanine |
| 03/16/2010 | US7678760 Inhibitors of Memapsin 2 and use thereof |
| 03/16/2010 | CA2160693C Oral drug delivery compositions and methods |
| 03/11/2010 | US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 03/11/2010 | US20100062937 Benzanilides with insecticidal activity |
| 03/11/2010 | US20100061959 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning |
| 03/10/2010 | EP1713510B1 Growth factor-binding compounds attached to a calixarene |
| 03/10/2010 | EP1494642B1 Organosilicon derivatives of aminohydroxybenzophenones and their use as UV-A filters in cosmetic preparations |
| 03/10/2010 | CN101668731A Albumin binding molecules and uses thereof |
| 03/09/2010 | US7674932 Method for the production of urea from natural gas |
| 03/04/2010 | WO2010024772A1 Aspartyl protease inhibitors |
| 03/04/2010 | WO2009149344A3 Solid states of aliskiren free base |
| 03/04/2010 | US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient |
| 03/04/2010 | US20100056508 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | CN101659627A High hydroxyl value bio-base polyol prepared by utilizing epoxidized vegetable oil through one-step reaction |
| 03/02/2010 | US7671082 4-Amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester; glutamate receptor agonist; antidepressant, anxiolytic agent psychological, and psychiatric disorders; acylation amino compounds with amino acyl, deprotection |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 02/25/2010 | WO2010021882A2 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010021351A1 Cycloalkylamine derivative |
| 02/25/2010 | US20100048909 such as (4S,5S) N-cyclopropyl-2-isopropyl-4-propyl-4,5-dihydro-1,3-oxazole-5-carboxamide; cost efficiency, industrial scale |
| 02/25/2010 | US20100048711 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 02/25/2010 | CA2735130A1 Compounds and methods for treating respiratory diseases |
| 02/24/2010 | EP2157096A1 Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate |
| 02/24/2010 | EP2157085A1 Oxazole, derivatives of tetracyclines |
| 02/24/2010 | EP2155663A1 Substituted 2- ý2- (phenyl) ethylamino¨alkaneamide derivatives and their use as sodium and/or calcium channel modulators |
| 02/24/2010 | CN101654417A Preparation method of X-ray contrast agent ioversol intermediate |
| 02/24/2010 | CN100591662C Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof |
| 02/23/2010 | US7666911 Self assembled nanostructures and methods for preparing the same |
| 02/23/2010 | US7666906 β-Benzyloxyaspartate derivatives with amino group on benzene ring |
| 02/18/2010 | WO2010018857A1 Method for producing amide derivative |
| 02/18/2010 | WO2010018714A1 Amide derivative, pest control agent containing the amide derivative and use of the pest control agent |
| 02/18/2010 | CA2733557A1 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative |
| 02/17/2010 | EP2154249A1 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/17/2010 | EP2154150A1 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | CN101648886A Green synthesis method of ioxilan |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/11/2010 | WO2010017470A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | WO2010015355A2 Novel acylaminobenzamide derivatives |
| 02/11/2010 | US20100036132 Process for the preparation of opiod modulators |
| 02/11/2010 | US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules |
| 02/11/2010 | US20100035991 Amide base salts of saha and polymorphis thereof |
| 02/11/2010 | US20100035869 Targeted nitroxide agents |
| 02/11/2010 | US20100035847 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/11/2010 | US20100035274 Methods for Detecting Symmetrical Dimethylarginine |
| 02/11/2010 | CA2733102A1 Novel acylaminobenzamide derivatives |
| 02/11/2010 | CA2732883A1 C7-fluoro substituted tetracycline compounds |
| 02/10/2010 | EP2150527A2 Anthranilic acid derivative as anticancer agent and a process for the preparation thereof |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2430273C Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2268403C Anthranilic acid derivatives as multi drug resistance modulators |
| 02/04/2010 | WO2010013567A1 Amide derivative, pest control agent containing the amide derivative and pest controlling method |
| 02/04/2010 | US20100029774 Aliskiren monofumarate and processes for preparation thereof |
| 02/04/2010 | CA2794350A1 Amide derivative, pest control agent containing the amide derivative, and pest controlling method |
| 02/04/2010 | CA2737348A1 Amide derivative, pest control agent containing the amide derivative, and pest controlling method |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | CA2480264C New preservatives and protective systems |
| 01/28/2010 | WO2010010380A1 Potassium ion channel modulators & uses thereof |
| 01/28/2010 | US20100022585 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/27/2010 | CN101636379A Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652002 9-aminoacyl tetracycline compounds and methods of use thereof |
| 01/26/2010 | CA2430293C A process for the preparation of n,n'-substituted 5-amino-1,3-benzenedicarboxamides |
| 01/21/2010 | US20100016636 process for preparing optical pure milnacipran and its pharmaceutically accepted salts |
| 01/21/2010 | US20100016611 Methods for making central nervous system agents that are trpv1 antagonists |
| 01/21/2010 | US20100016583 Compounds for treatment of copper overload |
| 01/21/2010 | US20100016403 Use of d-serine derivatives for the treatment of anxiety disorders |
| 01/21/2010 | CA2729919A1 Natural oil based autocatalytic polyols |
| 01/20/2010 | EP2145873A1 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode |
| 01/20/2010 | EP2144870A2 Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| 01/20/2010 | EP2144868A1 Process for purifying theanine |
| 01/20/2010 | EP2144594A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 01/20/2010 | EP1963277B1 Fluorinated compounds |
| 01/20/2010 | CN100582092C Method for producing diphenyl azetidinone derivatives |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/19/2010 | USRE41084 Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methyl propionic acid (CCI-779) and 4-dimethylamino-but-2-enoic acid(4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinol in-6-yl)amide (EKB-569); synergistic; antitumor agents |
| 01/19/2010 | US7649113 antiallergens for treating asthma, allergies, inflammatory conditions; side effect reduction; antiinflammatory agents |
| 01/19/2010 | US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 01/19/2010 | CA2427660C Biphenylcarboxamides useful as lipid lowering agents |
| 01/14/2010 | WO2010006085A1 Fatty acid acetylated salicylates and their uses |
| 01/14/2010 | US20100010094 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/14/2010 | US20100010012 Glutamate aggrecanase inhibitors |
| 01/14/2010 | US20100009397 Substrate-mimetic akt inhibitor |